Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-37,306
Closed -$2.74M 410
2021
Q1
$2.74M Buy
37,306
+3,680
+11% +$271K 0.23% 69
2020
Q4
$2.63M Sell
33,626
-1,880
-5% -$144K 0.25% 64
2020
Q3
$2.81M Buy
35,506
+19,780
+126% +$1.55M 0.29% 55
2020
Q2
$1.16M Sell
15,726
-11,284
-42% -$849K 0.12% 112
2020
Q1
$1.98M Sell
27,010
-82,601
-75% -$6.49M 0.21% 91
2019
Q4
$9.51M Buy
109,611
+665
+0.6% +$54.6K 0.83% 34
2019
Q3
$8.75M Sell
108,946
-94,263
-46% -$7.55M 0.86% 27
2019
Q2
$16.3M Sell
203,209
-830
-0.4% -$63.6K 1.64% 14
2019
Q1
$16.2M Buy
204,039
+71,601
+54% +$5.36M 1.63% 11
2018
Q4
$9.66M Sell
132,438
-2,425
-2% -$171K 1.11% 26
2018
Q3
$9.13M Sell
134,863
-167,367
-55% -$10.7M 0.94% 28
2018
Q2
$17.5M Sell
302,230
-5,904
-2% -$333K 1.86% 6
2018
Q1
$16M Buy
308,134
+212,256
+221% +$11.5M 1.8% 10
2017
Q4
$5.15M Buy
+95,878
New +$5.32M 0.6% 60

Other funds holding MRK

6 Meridian's MRK Position: Q2 2021 in Review

6 Meridian sold out of Merck (MRK) in Q2 2021, closing a stake of 37,306 shares — an estimated $2.74M sold.

6 Meridian first reported a position in MRK in Q4 2017 and held it in 14 quarters. The position peaked at $17.5M in Q2 2018. 2,674 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

  • 6 Meridian reported no remaining Merck position as of Q2 2021 after selling out during the quarter.
  • 6 Meridian sold 37,306 Merck shares in Q2 2021, an estimated $2.74M.
  • 6 Meridian first reported a position in Merck in Q4 2017 and held it in 14 quarters.
  • 6 Meridian's Merck position peaked at $17.5M in Q2 2018.
  • 2,674 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on 6 Meridian's 13F filing for Q2 2021, filed 14 Jul 2021.